摘要
目的分析生长抑制因子4(ING4)、缺氧诱导因子-1α(HIF-1α)在宫颈病变组织中的表达及与高危型HPV(HR-HPV)感染的关系。方法选取宫颈癌组织25份(宫颈癌组)、宫颈上皮内瘤变组织标本50份(CIN1组、CIN2-3组)、正常宫颈组织标本20份(正常组),术前检测HR-HPV,分析各组ING4、HIF-1α蛋白表达水平及其相关性、与病理参数关系。结果宫颈癌组、CIN1组、CIN2-3组HR-HPV感染率高于正常组(P<0.05);正常组ING4阳性率最高,而HIF-1α阳性率最低,宫颈癌组HIF-1α阳性率最高(P<0.05);感染HR-HPV的组织中,宫颈癌组ING4阳性率最低(P<0.05),而HIF-1α阳性率最高(P<0.05);在感染HR-HPV的宫颈癌及CIN2-3组织中,ING4与HIF-1α水平呈负相关(P<0.05);年龄、淋巴结转移、脉管浸润、肌层浸润深度为感染HR-HPV的宫颈癌患者ING4阴性且HIF-1α阳性的独立危险因素(P<0.05)。结论HR-HPV感染宫颈病变组织中ING4呈低表达,而HIF-1α呈高表达,从而抑制血管内皮细胞增殖、迁移,延缓宫颈病变进展。
Objective To analyze the expression of growth family member 4(ING4)and hypoxia-inducible factor-1α(HIF-1α)in cervical lesions,and its relationship with high-risk HPV(HR-HPV)infection.Methods 25 cervical cancer tissuesamples(cervical cancer group),50 cervical intraepithelial neoplasia(CIN)tissue samples(CIN1 group,CIN2-3 group)and 20 normal cervical tissue samples(normal group)were collected.HR-HPV was detected before surgery.The protein expression levels and correlation of ING4 and HIF-1αin each group,and their relationship with pathological parameters were analyzed.Results The HR-HPV infection rate was higher incervical cancer group,CIN1 group and CIN2-3 group than in the normal group(P<0.05).The ING4 positive rate was the highest,and the HIF-1αpositive rate was the lowest in the normal group.The HIF-1αpositive rate was the highest in the cervical cancer group(P<0.05).In HR-HPV infected tissues,the ING4 positive rate was the lowest,and the HIF-1αpositive rate was the highest in the cervical cancer group(P<0.05).There was a negative correlation between ING4 and HIF-1αlevels in HR-HPV infected cervical cancer and CIN2-3 tissues(P<0.05).Age,lymph node metastasis,vascular invasion,and the depth of myometrial invasion were independent risk factors for ING4 negative and HIF-1αpositive inpatients infected with HR-HPV(P<0.05).Conclusion The low expression of ING4 and high expression of HIF-1a in HR-HPV infected cervical lesions inhibit the proliferation and migration of vascular endothelial cells,thereby delaying the progression of cervical lesions.
作者
胡立娟
Hu Lijuan(Laboratory Department,Zhengzhou First People's Hospital,Zhengzhou 450001,China)
出处
《哈尔滨医药》
2023年第3期24-26,共3页
Harbin Medical Journal
基金
河南省医学科技攻关计划项目(LHGJ20210743)。